Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exatecan mesylate in advanced NSCLC
NCT00005091Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Feb 1999
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of exatecan in non-small cell lung cancer (NSCLC), sponsored by Daiichi Sankyo Co., Ltd.. Started Feb 1999; status: completed.
02
Drugs
exatecan
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00005091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005091.